Results 131 to 140 of about 1,255,487 (165)
Some of the next articles are maybe not open access.
Disease-a-Month, 2006
Eastern Europe, Henan province in China, and certain parts of Russia. 1 The resistance to single drug was reported to range from 2 to 41% (median 9.9%) and to multiple drugs was 0 to 14.4% (prevalence 1.4%) in those who never received prior treatment.
Joel Anthony, Nations +2 more
openaire +2 more sources
Eastern Europe, Henan province in China, and certain parts of Russia. 1 The resistance to single drug was reported to range from 2 to 41% (median 9.9%) and to multiple drugs was 0 to 14.4% (prevalence 1.4%) in those who never received prior treatment.
Joel Anthony, Nations +2 more
openaire +2 more sources
Molecular Genetics, Microbiology and Virology (Russian)
Genetic control of different pathways of drug-resistance formation in bacteria is presented. Possible molecular mechanisms of “new” genes integration into the genomes by horizontal gene transfer are discussed. This review may be valuable for physicians, veterinarians and scientific researches engaged in bacterial evolution.
openaire +1 more source
Genetic control of different pathways of drug-resistance formation in bacteria is presented. Possible molecular mechanisms of “new” genes integration into the genomes by horizontal gene transfer are discussed. This review may be valuable for physicians, veterinarians and scientific researches engaged in bacterial evolution.
openaire +1 more source
Current Opinion in Pulmonary Medicine, 2000
There is increasing concern in many countries about the problem of drug-resistant tuberculosis, particularly so because no new classes of drugs have been developed for the treatment of tuberculosis since the 1960s. Although drug resistance is thought to be fairly common in some countries and rare in others, the global extent of this condition is not ...
openaire +2 more sources
There is increasing concern in many countries about the problem of drug-resistant tuberculosis, particularly so because no new classes of drugs have been developed for the treatment of tuberculosis since the 1960s. Although drug resistance is thought to be fairly common in some countries and rare in others, the global extent of this condition is not ...
openaire +2 more sources
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
Ca-A Cancer Journal for Clinicians, 2022Paolo Tarantino +2 more
exaly
Targeted drug delivery strategies for precision medicines
Nature Reviews Materials, 2021Mandana T Manzari +2 more
exaly
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
Nature Reviews Microbiology, 2022Véronique A Dartois, Eric J Rubin
exaly